Streptavidine, min 15 U/mg, lyophilisée, 10 mg, emballage plastique.

Benzoic acid, 4-[[[(8-chloro-1,4-dihydro-1-methyl[1]benzopyrano[4,3-c]pyrazol-3-yl)carbonyl](phenylmethyl)amino]methyl]-, 50mg

4-Acetoxyphenylboronic Acid (contains varying amounts of Anhydride)1g

3-(1,3-benzothiazol-2-yl)-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-amine, 95.0%, 250mg

5-Bromo-4-ethoxy-2-((4-methoxybenzyl)oxy)pyridine, 97%, 250mg

2-(1-methyl-1H-pyrazol-3-yl)acetic acid hydrochloride, 95.0%, 2.5g

3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxylic acid, 95.0%, 1g

6-CHLORO-5-(4-(1-HYDROXYCYCLOBUTYL)PHENYL)-1H-INDOLE-3-CARBOXYLIC ACID, 95.0%, 5mg

4-Methoxyphenylacetic Acid>98.0%(GC)(T)100g

(R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethan-1-amine, 97%, 10g

4-hydroxy-3,3-dimethyl-2-Butanone, 95.0%, 100mg

1-Pyrazin-2-yl-ethylamine, 97.0%, 25g

(3-Fluoro-5-formylphenyl)boronic acid, 97%, 5g